-
December 30, 2014 Lupin Receives Tentative Approval for Generic Prezista® Tablets
-
December 26, 2014 Lupin Receives FDA Approval for Generic Epivir® Tablets
-
December 11, 2014 Lupin Launches Authorized Generic for Celebrex® Capsules
-
November 3, 2014 Lupin Receives FDA Approval for Generic Celebrex® Capsules
-
October 28, 2014 Quarter II Results, FY 2014-15
-
September 16, 2014 Lupin Announces Strategic Alliance for Emerging Markets
-
September 12, 2014 Lupin and Salix Announce Exclusive Distribution Agreement for Canada, Zaxine®, Relistor® and Other Gastroenterology Products
-
August 6, 2014 Lupin launches Basugine™
-
July 30, 2014 Quarter I Results, FY 2014-15
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications